Clinical Trial Update: A Clinical Study Evaluating the Safety and Efficacy of Local Injection of ACT#001 Chimeric Antigen Receptor T Cells in the Treatment of Castration-Resistant Prostate Cancer [EARLY_Phase 1]

View source ↗

Summary

This early-phase clinical trial updates on the safety and efficacy of locally injected ACT#001 CAR-T cells for castration-resistant prostate cancer and is not y…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• ACT#001 CAR-T cells

Snippet

Sponsor: Zhejiang University | Conditions: Castration-Resistant Prostate Cancer (CRPC) | EARLY_Phase 1 | Status: NOT_YET_RECRUITING